Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 923,000 | 816,000 | 779,000 | 603,000 | 674,812 |
| Cost of Goods | 48,000 | 40,000 | 28,000 | 27,000 | 18,215 |
| Gross Profit | 875,000 | 776,000 | 751,000 | 576,000 | 656,597 |
| Operating Expenses | 565,000 | 466,000 | 515,000 | 460,000 | 416,568 |
| Operating Income | 310,000 | 310,000 | 236,000 | 116,000 | 240,244 |
| Interest Expense | 109,000 | 101,000 | 46,000 | 35,000 | 65,625 |
| Other Income | 316,000 | 44,000 | 117,000 | 168,000 | -43,561 |
| Pre-tax Income | 517,000 | 253,000 | 307,000 | 249,000 | 131,058 |
| Income Tax | -35,000 | 67,000 | 104,000 | 57,000 | 40,805 |
| Net Income Continuous | 552,000 | 186,000 | 203,000 | 192,000 | 90,252 |
| Net Income | $552,000 | $186,000 | $203,000 | $192,000 | $90,252 |
| EPS Basic Total Ops | 0.86 | 0.29 | 0.32 | 0.30 | 0.14 |
| EPS Basic Continuous Ops | 0.86 | 0.29 | 0.32 | 0.30 | 0.14 |
| EPS Diluted Total Ops | 0.85 | 0.29 | 0.31 | 0.29 | 0.13 |
| EPS Diluted Continuous Ops | 0.85 | 0.29 | 0.31 | 0.29 | 0.13 |
| EPS Diluted Before Non-Recurring Items | 0.57 | 0.29 | 0.22 | N/A | N/A |
| EBITDA(a) | $327,000 | $326,000 | $250,000 | $129,000 | $240,244 |